Pharmacological inhibition on the ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR; also referred to as FRAP-similar protein (FRP1)) has emerged being a promising system for cancer procedure that exploits synthetic lethal interactions with proteins involved with DNA harm maintenance, overcomes resistance to other therapies and enhances antitumour immunity. N... https://barryq887bmx0.blog-gold.com/profile